A Pan-Cancer Analysis of the TME Shows Reproducibility but Tissue-Dependent Associations between RNA-based Immune Signatures, Tumor Mutational Burden, and Outcomes

Get in Touch

Our Locations

Wendell Jones, Ph.D.

A Pan-Cancer Analysis of the TME Shows Reproducibility but Tissue-Dependent Associations between RNA-based Immune Signatures, Tumor Mutational Burden, and Outcomes

Q2 Solutions Immune Landscape Signatures

This presentation, presented at the 2019 MAQC Society conference, discusses 3 types of Reproducibility related to RNA-based Immune Signatures in the Tumor MicroEnvironment (TME).
Download presentation to learn more.

Related Services & Solutions

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q² Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q² Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...